REQUEST A DEMO
Total
USD $0.00
Search more companies

Orfeus Pharma OOD (Орфеус Фарма ЕООД) (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Orfeus Pharma OOD Profile Updated: October 07, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Orfeus Pharma OOD (Орфеус Фарма ЕООД) is an enterprise in Bulgaria, with the main office in Vidin. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on January 20, 2026. 1 (2023) employees currently work for Orfeus Pharma OOD (Орфеус Фарма ЕООД). The net profit margin of Orfeus Pharma OOD (Орфеус Фарма ЕООД) decreased by 0.04% in 2022.

Headquarters
Ul. Ekzarh Yosif I 23, Vh. A, ET. 2, Ap. 4
Vidin; Vidin; Postal Code: 3700

Contact Details: Purchase the Orfeus Pharma OOD (Орфеус Фарма ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the Orfeus Pharma OOD (Орфеус Фарма ЕООД) report to view the information.
Registered Capital:
Purchase the Orfeus Pharma OOD (Орфеус Фарма ЕООД) report to view the information.
Financial Auditors:
Purchase the Orfeus Pharma OOD (Орфеус Фарма ЕООД) report to view the information.
Incorporation Date:
January 20, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Orfeus Pharma OOD (Орфеус Фарма ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Total operating revenue
36.75%
Operating Profit Margin (ROS)
-0.04%
Net Profit Margin
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?